Literature DB >> 20598285

ProCGlobal and endogenous thrombin potential during pregnancy.

Gregor Hron1, Paul A Kyrle, Alexandra Kaider, Karl Philipp, Ingrid Pabinger, Marietta Kollars, Sabine Eichinger.   

Abstract

OBJECTIVE: Pregnancy is a hypercoagulable state. We evaluated global markers of coagulation activation, ProCGlobal (Siemens Healthcare Diagnostics, Eschborn, Germany) and endogenous thrombin potential (ETP), in pregnant women with and without low-molecular-weight (LMW) heparin prophylaxis. STUDY
DESIGN: We prospectively followed 113 healthy women and 61 women receiving LMW heparin prophylaxis throughout pregnancy. ProCGlobal and ETP were measured in venous blood during the first, second, and third trimester.
RESULTS: ProCGlobal decreased significantly throughout pregnancy in all women and was lower in anticoagulated women (P < .001 for all comparisons). ETP levels remained unchanged until the third trimester and then significantly decreased in all women. ETP was higher in anticoagulated women than in healthy women at all time points.
CONCLUSION: ProCGlobal levels decrease throughout pregnancy. In pregnant women at high thrombotic risk, coagulation activation reflected by low ProCGlobal and high ETP levels is substantial despite LMW heparin prophylaxis.
Copyright © 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20598285     DOI: 10.1016/j.ajog.2010.05.034

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  Tissue factor-dependent thrombin generation across pregnancy.

Authors:  Kelley C McLean; Ira M Bernstein; Kathleen E Brummel-Ziedins
Journal:  Am J Obstet Gynecol       Date:  2012-06-11       Impact factor: 8.661

2.  Reduced protein C Global assay level in infertile women prior to IVF-ET treatment.

Authors:  Johnny S Younis; Moshe Ben-Ami; Ido Izhaki; Benjamin Brenner; Galit Sarig
Journal:  J Assist Reprod Genet       Date:  2013-11-06       Impact factor: 3.412

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.